Nov 10, 2021
|
Lumos Pharma to Participate in Upcoming Investor Conferences
|
|
Nov 3, 2021
|
Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates
|
|
Oct 21, 2021
|
Lumos Pharma to Report Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021
|
|
Sep 2, 2021
|
Lumos Pharma to Participate in September Investor Conferences
|
|
Aug 5, 2021
|
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
|
|
Aug 3, 2021
|
Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
|
|
Aug 2, 2021
|
Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
|
|
Jul 26, 2021
|
Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
|
|
Jul 22, 2021
|
Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021
|
|
Jul 20, 2021
|
Lumos Pharma Announces Clinical Updates
|
|